Piramal Pharma Limited PPLPHARMA.NS · Stock Open Piramal Pharma Limited in new tab
Piramal Pharma Limited Analysis (PPLPHARMA.NS)
Is Piramal Pharma Limited a good investment? Piramal Pharma Limited (PPLPHARMA.NS) is currently trading at 202.50 INR. Market analysts have a consensus price target of 205.27 INR. This suggests a potential upside from current levels.
Earnings Schedule: Piramal Pharma Limited is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 4.22.
For income investors, Piramal Pharma Limited pays a dividend yield of 0.07%. With a payout ratio of -6%, the dividend appears sustainable.
Investor FAQ
Does Piramal Pharma Limited pay a dividend?
Yes, it pays an annual dividend of 0.14 INR (0.07% yield).
What asset class is Piramal Pharma Limited?
Piramal Pharma Limited is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of -2.48.
Company Profile
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids' wellness, digestives, and women's health, as well as geriatric care. The company was incorporated in 2020 and is based in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.14 INR
|
| Aug. 31, 2026 (estimated) | 0.1400 |
| ▸2025 |
0.14 INR
|
| Aug. 29, 2025 | 0.1400 |
| ▸2024 |
0.11 INR
|
| July 26, 2024 | 0.1100 |
Community Discussion